Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Oct 7;20:15330338211041464. doi: 10.1177/15330338211041464

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2021

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 3. — EIF3B expression at baseline and after 4-week therapy in adult Ph⁻ ALL patients. Comparison of EIF3B expression between baseline and after 4-week therapy in total adult Ph⁻ ALL patients (A). Comparison of EIF3B expression between baseline and after 4-week therapy in adult Ph⁻ ALL patients who received CR within 4 weeks (B). Comparison of EIF3B expression between baseline and after 4-week therapy in adult Ph⁻ ALL patients who did not receive CR within 4 weeks (C).

Abbreviations: EIF3B, eukaryotic translation initiation factor 3 subunit B; Ph⁻ ALL, Philadelphia chromosome⁻ negative acute lymphoblastic leukemia; CR, complete remission.